What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2023-02-28 compared with 2022-03-01 · 32 added, 21 removed, 20 unchanged (73% of the section changed)

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market for Registrant’s Common Equity, Related

Stockholder Matters and Issuer Purchases of Equity Securities

The Market for Our Common Stock

Our Company’s common stock, $.001 par value per share, is traded on The Nasdaq Global Select Market under the symbol “IPAR”.

The following table sets forth in dollars, the range of high and low closing prices for the past two fiscal years for our common stock.

Our Company’s common stock, $.001

par value per share, is traded on The Nasdaq Global Select Market under the symbol “IPAR”.

The following table sets

forth in dollars, the range of high and low closing prices for the past two fiscal years for our common stock.

High Closing Price

10 unchanged sentences

First Quarter

As of February 8, 2022, the number of record holders, which include brokers and broker nominees, etc., of our common stock was 32.

We believe there are approximately 15,700 beneficial owners of our common stock.

As of February 8, 2023, the number of record

holders, which include brokers and broker nominees, etc., of our common stock was 28.

We believe there are approximately 32,436

beneficial owners of our common stock.

Corporate Performance Graph

The following graph compares the performance for the periods indicated in the graph of our common stock with the performance of the Nasdaq Market Index and the average performance of a group of the Company’s peer corporations consisting of:

CCA Industries, Inc., Colgate-Palmolive Co., Estée Lauder Companies, Inc., Inter Parfums, Inc., Kimberly Clark Corp., Natural Health Trends Corp., Procter & Gamble Co., Revlon, Inc., Stephan Co., Summer Infant, Inc.

The following graph compares the performance

for the periods indicated in the graph of our common stock with the performance of the Nasdaq Market Index and the average performance

of a group of the Company’s peer corporations consisting of:

CCA Industries, Inc., Colgate-Palmolive Co., Estée Lauder

Companies, Inc., Inter Parfums, Inc., Kimberly Clark Corp., Natural Health Trends Corp., Procter & Gamble Co., Stephan Co.,

Summer Infant, Inc.

and United Guardian, Inc.

The graph assumes that the value of the investment in our common stock and each index was $100 at the beginning of the period indicated in the graph, and that all dividends were reinvested.

COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*

The graph assumes that the value of the investment in our common stock and each index

was $100 at the beginning of the period indicated in the graph, and that all dividends were reinvested.

COMPARISON OF 5 YEAR CUMULATIVE TOTAL

Among Inter Parfums, Inc., the NASDAQ Composite Index,

and a Peer Group

*$100 invested on 12/31/16 in stock or index, including reinvestment of dividends.

*$100 invested on 12/31/17 in stock or index, including reinvestment

of dividends.

Fiscal year ending December 31.

Below is the list of the data points for each year that corresponds to the lines on the above graph.

Below is the list of the data points for

each year that corresponds to the lines on the above graph.

Inter Parfums, Inc.

NASDAQ Composite

In October 2019, our Board of Directors authorized a 20% increase in the annual dividend to $1.32 per share on an annual basis.

In April 2020, as a result of the uncertainties raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the annual cash dividend.

In February 2021, our Board of Directors authorized a reinstatement of an annual dividend of $1.00, payable quarterly.

In February 2022, our Board of Directors authorized a 100% increase in the annual dividend to $2.00 per share.

The next quarterly cash dividend of $0.50 per share is payable on March 31, 2022, to shareholders of record on March 15, 2022.

Sales of Unregistered Securities

In December 2021, our non-employee directors exercised stock options to purchase an aggregate of 2,500 shares of restricted common stock.

These transactions were exempt from the registration requirements of Section 5 of the Securities Act under Sections 4(2) and 4(6) of the Securities Act.

Each option holder agreed that, if the option is exercised, the option holder would purchase his or her common stock for investment and not for resale to the public.

Also, we provide all option holders with all reports we file with the SEC and press releases issued by us.

In April 2020, as a result of the uncertainties

raised by the COVID-19 pandemic, the Board of Directors authorized a temporary suspension of the annual cash dividend.

2021, the Board of Directors authorized a reinstatement of an annual dividend of $1.00, payable quarterly.

In February 2022, the

Board of Directors authorized a 100% increase in the annual dividend to $2.00 per share.

Just recently, in February 2023 the Board

of Directors further increased the annual dividend to $2.50 per share.

The next quarterly cash dividend of $0.625 per share is

payable on March 31, 2023 to shareholders of record on March 15, 2023.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity